April 6, 2018 | Blake Mossy
OrthoD entered into an agreement to be acquired by Apposite Capital, a healthcare focused private equity firm. OrthoD is a specialist manufacturer and distributor of medical products and implants for joint reconstruction, sport medicine, surgical products and infection control applications. The company’s products range from bone cement management systems, wound drainage, fixation devices for knee and shoulder surgery and other specialist devices. The terms of this agreement have not been disclosed.
CTL Medical received 510(k) approval from the FDA for its SEURAT Universal Pedicle Screw, designed for direct implantation into a vertebral pedicle. The system utilizes a modular housing assembly option and choice of standard or reinforced-ring locking set screw, aiming to allow surgeons to customized the implant per patient needs. The system is comprised of polyaxial and monoaxial, open and MIS, single and dual thread profiles, solid and cannulated and hex and hexalobe screws of all diameters and lengths.
CurveBeam received CE Mark approval from the FDA for its LineUP in InReach orthopedic extremity CT imaging systems. The systems aim to provide radiology and orthopedic specialists with three-dimensional bone and can be plugged into a standard wall outlet and have minimal shielding requirements. The LineUP system permits the patient to stand during the scan, so anatomy can be assessed while in the “weight bearing” or “load bearing” position and can perform bilateral scans of the entire leg. InReach is designed for hand, wrist and elbow in non-load bearing positions.
Episurf Medical received approval from Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) for its Episealer knee implant for marketing and sale in Spain. The approval follows a review process and Episurf Medical will now continue the process of establishment on the Spanish market. The company has developed Episealer personalized implants and Epiguide surgical drill guides to treat localized joint cartilage injury.
PRODUCT INTRODUCTION & UPDATE
AlloSource and Stryker launched its ProChondrix CR cryopreserved osteochondral allograft, designed for articular cartilage repair. The system aims to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function.
Globus Medical launched its ELSA AL and ELSA-ATP lateral expandable interbody spacers with integrated screw fixation, designed to allow restoration of sagittal balance and enhanced structural fixation. ELSA AL utilizes an adjustable lordotic technology that allows up to 30 degrees of lordosis while maintaining a minimally invasive surgical corridor. ELSA-ATP is an expandable spacer designed to avoid nerve complications associated with direct lateral
NuVasive launched its MAS (Maximum Access Surgery) ALIF (Anterior Lumber Interbody Fusion) retractor platform for both lateral and supine surgery approaches. The system enables single-position surgery for multilevel cases when integrated with the NuVasive XLIF procedure, increasing O.R. efficiency by reducing the number of times a patient has to be repositioned and expanding the benefits of lateral surgery to more spinal levels.
RTI Surgical announced a milestone of providing 8 million biologic implants with zero confirmed incidence of implant-associated infection. The company’s RTIX tissue-specific sterilization services include BioCleanse for grafts used in orthopedic, spine and sports medicine procedures, the Cancelle SP DMB Sterilization Process and the Tutoplast Tissue Sterilization Process.
Zimmer Biomet announced the completion of its first surgical case using its Comprehensive Augmented Baseplate, a part of its Comprehensive Reverse Shoulder System, offering an alternative to bone grafting and eccentric reaming for patients with glenoid defects undergoing shoulder reconstruction.
Smith & Nephew appointed Mr. Namal Nawana as Chief Executive Officer and join the Board as Executive Director. Most recently, Mr. Nawana served as CEO of medical diagnostics company Alere Inc., prior to Alere, he spent 15 years at Johnson & Johnson primarily in its Medical Device & diagnostics segment. Mr Nawana will succeed Olivier Bohuon, who will step down from the Board.